Literature DB >> 17635861

Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.

Stephen J Juris1, Roman A Melnyk, Robert E Bolcome, Joanne Chan, R John Collier.   

Abstract

The proteins that comprise anthrax toxin self-assemble at the mammalian cell surface into a series of toxic complexes, each containing a heptameric form of protective antigen (PA) plus up to a total of three molecules of the enzymatic moieties of the toxin (lethal factor [LF] and edema factor [EF]). These complexes are trafficked to the endosome, where the PA heptamer forms a pore in the membrane under the influence of low pH, and bound LF and EF unfold and translocate through the pore to the cytosol. To explore the hypothesis that the PA pore can translocate multiple, cross-linked polypeptides simultaneously, we cross-linked LF(N), the N-terminal domain of LF, via an introduced cysteine at its N or C terminus and characterized the products. Both dimers and trimers of LF(N) retained the ability to bind to PA pores and block ion conductance, but they were unable to translocate across the membrane, even at high voltages or with a transmembrane pH gradient. The multimers were remarkably potent inhibitors of toxin action in mammalian cells (20- to 50-fold more potent than monomeric LF(N)) and in a zebrafish model system. These findings show that the PA pore cannot translocate multimeric, cross-linked polypeptides and demonstrate a new approach to generating potent inhibitors of anthrax toxin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635861      PMCID: PMC2044540          DOI: 10.1128/IAI.00490-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Protein translocation through anthrax toxin channels formed in planar lipid bilayers.

Authors:  Sen Zhang; Eshwar Udho; Zhengyan Wu; R John Collier; Alan Finkelstein
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

2.  Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of anthrax toxin.

Authors:  Bryan A Krantz; Amar D Trivedi; Kristina Cunningham; Kenneth A Christensen; R John Collier
Journal:  J Mol Biol       Date:  2004-11-26       Impact factor: 5.469

3.  Chemical approaches to angiogenesis.

Authors:  Joanne Chan; Fabrizio C Serluca
Journal:  Methods Cell Biol       Date:  2004       Impact factor: 1.441

4.  Crystal structure of the anthrax toxin protective antigen.

Authors:  C Petosa; R J Collier; K R Klimpel; S H Leppla; R C Liddington
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

5.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Authors:  N S Duesbery; C P Webb; S H Leppla; V M Gordon; K R Klimpel; T D Copeland; N G Ahn; M K Oskarsson; K Fukasawa; K D Paull; G F Vande Woude
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

6.  Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha.

Authors:  R Pellizzari; C Guidi-Rontani; G Vitale; M Mock; C Montecucco
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

7.  A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformation.

Authors:  Roman A Melnyk; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

8.  Anthrax protective antigen: prepore-to-pore conversion.

Authors:  C J Miller; J L Elliott; R J Collier
Journal:  Biochemistry       Date:  1999-08-10       Impact factor: 3.162

9.  Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.

Authors:  G Vitale; R Pellizzari; C Recchi; G Napolitani; M Mock; C Montecucco
Journal:  Biochem Biophys Res Commun       Date:  1998-07-30       Impact factor: 3.575

10.  Characterization of membrane translocation by anthrax protective antigen.

Authors:  J Wesche; J L Elliott; P O Falnes; S Olsnes; R J Collier
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

View more
  6 in total

1.  A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells.

Authors:  Heather K Kroh; Ramyavardhanee Chandrasekaran; Zhifen Zhang; Kim Rosenthal; Rob Woods; Xiaofang Jin; Andrew C Nyborg; G Jonah Rainey; Paul Warrener; Roman A Melnyk; Benjamin W Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2017-11-27       Impact factor: 5.157

2.  Binding and cell intoxication studies of anthrax lethal toxin.

Authors:  Momchilo Vuyisich; Claire K Sanders; Steven W Graves
Journal:  Mol Biol Rep       Date:  2012-01-05       Impact factor: 2.316

3.  Constitutive MEK1 activation rescues anthrax lethal toxin-induced vascular effects in vivo.

Authors:  Robert E Bolcome; Joanne Chan
Journal:  Infect Immun       Date:  2010-09-20       Impact factor: 3.441

4.  Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature.

Authors:  Robert E Bolcome; Sarah E Sullivan; René Zeller; Adam P Barker; R John Collier; Joanne Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

5.  The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.

Authors:  Melissa L Nguyen; Simon Terzyan; Jimmy D Ballard; Judith A James; A Darise Farris
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

6.  Cys-Cys cross-linking shows contact between the N-terminus of lethal factor and Phe427 of the anthrax toxin pore.

Authors:  Blythe E Janowiak; Laura D Jennings-Antipov; R John Collier
Journal:  Biochemistry       Date:  2011-04-06       Impact factor: 3.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.